Cartesian Growth Corporation II
Cartesian Growth Corporation II (RENEU) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
reneu · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Cartesian Growth Corporation II (RENEU) measures how much investors pay for each dollar of the company's trailing earnings. RENEU's current PE ratio of 36.11x is calculated by dividing its stock price of $11.69 by its TTM earnings per share of $0.33. +20.2% elevated vs 5Y avg 30.0x
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2021 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 3 fiscal years · Front-end computedMinQ1 · 25%26.5x
MedianQ3 · 75%42.9x
Max
At 36.11x, RENEU's current P/E is within its average historical range over the past 3 fiscal years.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Shell Companies · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Cartesian Growth Corporation IIYou RENEU | $153M | 36.11x | +13.4% | $0.33 |
 Blockchain Coinvestors Acquisition Corp. I BCSA | $149M | 31.06x | -2.4% | $0.35 |
 Battery Future Acquisition Corp. BFAC | $154M | 60.28x | +89.4% | $0.18 |
 Forest Road Acquisition Corp. II FRXB | $138M | 39.02x | +22.6% | $0.26 |
 HH&L Acquisition Co. HHLA | $157M | 13.13x | -58.8% | $0.77 |
 LAVA Medtech Acquisition Corp. LVAC | $150M | 32.52x | +2.1% | $0.31 |
 M3-Brigade Acquisition II Corp. MBAC | $154M | 14.99x | -52.9% | $0.67 |
Industry Average 6 peers with valid PE | — | 31.83x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-0.23 | — | |
2024-12-31 FY2024 | 20.71x | $0.56 | -21.9% | |
2023-12-31 FY2023 | 26.50x | $0.41 | -38.2% | |
2022-12-31 FY2022 | 42.88x | $0.24 | — | |
2021-12-31 FY2021 | — | $-0.00 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Cartesian Growth Corporation II (RENEU) measures how much investors pay for each dollar of the company's trailing earnings. RENEU's current PE ratio of 36.11x is calculated by dividing its stock price of $11.69 by its TTM earnings per share of $0.33.
Frequently asked questions
RENEU pe ratio · 6 questionsRENEU's current PE ratio is 36.11x as of 2026-06-09, based on a stock price of $11.69 and TTM EPS of $0.33. Data sourced from Financial Modeling Prep via RENEU's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Cartesian Growth Corporation II SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09